Mirum Pharmaceuticals, Inc. - common stock (MIRM) Social Stream



Mirum Pharmaceuticals, Inc. - common stock (MIRM): $29.27

0.56 (+1.95%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

MIRUM PHARMACEUTICALS INC (MIRM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MIRM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-17 5 $77 $30 $51.833 $26.88 92.83%
2021-11-18 5 $77 $30 $52 $26.88 93.45%
2022-01-12 5 $77 $30 $52.166 $26.88 94.07%
2022-03-09 5 $77 $30 $52.833 $26.88 96.55%
2022-03-14 5 $77 $30 $53.5 $26.88 99.03%
2022-05-05 5 $77 $30 $59.2 $26.88 120.24%
2022-05-20 5 $77 $32 $59.6 $26.88 121.73%
2022-05-23 5 $77 $32 $60.6 $26.88 125.45%
2022-05-26 5 $77 $32 $61 $26.88 126.93%
2022-08-08 4 $77 $31 $60.8 $26.88 126.19%
2022-08-11 5 $77 $31 $59.6 $26.88 121.73%
2022-08-16 5 $77 $31 $59 $26.88 119.49%
2022-09-01 5 $77 $31 $55.5 $26.88 106.47%
2022-10-24 6 $77 $31 $55.5 $26.88 106.47%
2022-10-25 6 $88 $31 $58.5 $26.88 117.63%
2022-11-10 6 $88 $31 $57.833 $26.88 115.15%
2022-11-14 6 $88 $31 $58 $26.88 115.77%
2022-12-05 6 $88 $30 $57.833 $26.88 115.15%
2022-12-14 6 $88 $30 $58 $26.88 115.77%
2023-01-23 6 $84 $30 $55.5 $26.88 106.47%
2023-02-16 6 $84 $30 $54.166 $26.88 101.51%
2023-03-10 6 $83 $30 $53.833 $26.88 100.27%
2023-06-08 5 $81 $34 $58.2 $26.88 116.52%
2023-07-18 5 $82 $34 $59.8 $26.88 122.47%
2023-08-04 4 $79 $34 $55.25 $26.88 105.54%
2023-08-07 4 $79 $34 $55 $26.88 104.61%
2023-08-21 4 $84 $34 $56.25 $26.88 109.26%
2023-09-22 5 $84 $34 $59 $26.88 119.49%
2023-10-03 6 $84 $34 $55.5 $26.88 106.47%
2023-10-17 6 $84 $34 $56.428 $26.88 109.93%
2023-10-19 7 $77 $34 $55.428 $26.88 106.21%
2023-11-03 7 $77 $34 $54.75 $26.88 103.68%
2023-11-04 7 $78 $34 $55 $26.88 104.61%
2023-11-13 8 $78 $34 $55.555 $26.88 106.68%
2023-12-14 9 $78 $34 $53.7 $26.88 99.78%
2023-12-18 9 $78 $34 $53.4 $26.88 98.66%
2023-12-19 9 $70 $33 $49.5 $26.88 84.15%

The Trend in the Analyst Price Target


MIRM's average price target has moved down $0.79 over the prior 33 months.

MIRM reports an average of 98.97% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-05 6 81 30 53.50 26.23 103.96%
2023-07-18 4 82 34 59.80 27.21 119.77%
2023-10-03 6 84 34 55.50 29.77 86.43%
2023-11-03 7 77 34 54.75 30.00 82.5%
2023-11-20 9 78 34 53.70 32.10 67.29%

MIRM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 9 0 0 0 0 9

The Trend in the Broker Recommendations


Over the past 13 months, MIRM's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MIRM as an investment opportunity.

  • In the context of all US stocks, MIRUM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -3808.9% of them.
  • MIRM has a greater upside potential (average analyst target price relative to current price) than 3781.22% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, MIRUM PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1237.72% of them.
  • In the context of stocks in the small market cap category, MIRUM PHARMACEUTICALS INC's average analyst price target is greater than 4386.38% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MIRUM PHARMACEUTICALS INC are FULC, BCEL, and BCYC.

Is MIRM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!